Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

101. A meta-analysis of interventions to promote mammography among ethnic minority women (Full text)

A meta-analysis of interventions to promote mammography among ethnic minority women A meta-analysis of interventions to promote mammography among ethnic minority women A meta-analysis of interventions to promote mammography among ethnic minority women Han HR, Lee JE, Kim J, Hedlin HK, Song H, Kim MT CRD summary The authors concluded that findings suggested a need for increased use of a therapy-based tailored approach with enhancement of access to improve mammography screening rates among women (...) from ethnic minorities. The review was generally well-conducted, but the conclusions were based on subgroup analyses of diverse studies of uncertain quality and should be interpreted with caution. Authors' objectives To evaluate the effectiveness of interventions aimed at increasing mammography screening rates in asymptomatic ethnic minority women in USA. Searching MEDLINE, CINAHL, PsycINFO and Web of Science were searched for studies published in English from 2000 to August 2008. Key words were

2009 DARE. PubMed

102. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines (Full text)

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Ahern CH, Shen Y Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to assess the cost-effectiveness of breast cancer screening strategies that combined mammography and clinical breast examination. The authors suggested that, due to its superior cost-effectiveness, the strategy of mammography and clinical breast examination every two years, and given

2009 NHS Economic Evaluation Database. PubMed

103. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) that for organised screening. There were a few limitations to the study, but the methods and results were presented well, and the authors’ conclusions appear to be appropriate. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The objective was to compare the cost-effectiveness of alternative screening programmes for breast cancer in women aged 50 to 69 years in Switzerland. Interventions Organised biennial mammography screening was compared with opportunistic

2009 NHS Economic Evaluation Database.

104. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

105. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

106. Premedication to Reduce Discomfort during Screening Mammography (PubMed)

Premedication to Reduce Discomfort during Screening Mammography To test the hypothesis that premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel would decrease discomfort and improve satisfaction with screening mammography in women who expect a higher level of discomfort.In this HIPAA-compliant, institutional review board-approved, prospective, double-blinded, placebo-controlled clinical trial, 418 women aged 32-89 years who expected substantial discomfort with screening (...) mammography were randomly divided to receive premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel. Subjects provided informed written consent. The primary outcome was discomfort. Secondary outcomes were satisfaction and plans for future mammography on the basis of discomfort. Subjects completed structured questionnaires with visual analog scales to measure discomfort and satisfaction. A generalized linear mixed-models framework was used to assess the effect of medications on discomfort

2008 EvidenceUpdates

107. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Article Text Treatment Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright

2008 Evidence-Based Nursing

108. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy (Full text)

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy The effect of combined hormone therapy on breast cancer detection is not established.We examined the effect of combined hormone therapy on breast cancer detection in the Women's Health Initiative trial, which randomized 16,608 postmenopausal women to receive conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo. Mammography and breast examinations were (...) performed at baseline and annually per protocol, with breast biopsies based on clinical findings. The effects of conjugated equine estrogens plus medroxyprogesterone acetate on breast cancer detection was determined throughout 5.6 years of intervention using receiver operating characteristic analyses to evaluate mammography results.Conjugated equine estrogens plus medroxyprogesterone acetate increased the cumulative frequency of mammograms with abnormalities vs placebo (35.0% vs 23.0%; P < .001), which

2008 EvidenceUpdates PubMed

109. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient

2008 American Cancer Society

110. Effect of cost sharing on screening mammography in medicare health plans. (PubMed)

Effect of cost sharing on screening mammography in medicare health plans. Policies that increase patients' share of health care expenses decrease the use of discretionary health services but also may reduce the use of important preventive care such as mammography.We reviewed coverage for mammography within 174 Medicare managed-care plans from 2001 through 2004. Among 550,082 individual-level observations for 366,475 women between the ages of 65 and 69 years, we compared rates of biennial breast (...) -cancer screening in plans requiring cost sharing for mammography with screening rates in plans with full coverage. We also performed a longitudinal analysis of screening rates in plans that changed from full coverage to cost sharing for mammography as compared with rates in matched control plans that did not institute cost sharing.The number of plans with cost sharing for mammography, which we defined as requiring a copayment of more than $10 or coinsurance of more than 10% for screening mammography

2008 NEJM

111. Interventions for relieving the pain and discomfort of screening mammography. (PubMed)

Interventions for relieving the pain and discomfort of screening mammography. The pain of mammography is recognised as a significant deterrent for women considering this examination, and may affect participation in breast screening.To review interventions to reduce or relieve the pain and discomfort of screening mammography.For this update, the Cochrane Breast Cancer Group Specialised Register was searched on the 18th May 2006. Other databases searched were MEDLINE (1966 to November 2006 (...) experienced was unchanged. The use of breast cushions reduced pain of mammography; however, image quality was impaired in 2% of women in the intervention group. Acetoaminophen as a premedication did not affect discomfort of mammography. Differences in interventions, and inconsistency in measures, validation of pain scales, and in assessment of mammogram quality, mean that results of these studies cannot be combined. All results are based on single studies. Further research is required.Currently

2008 Cochrane

112. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. (Full text)

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Screening ultrasound may depict small, node-negative breast cancers not seen on mammography.To compare the diagnostic yield, defined as the proportion of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer.From April 2004 to February (...) (assessed by the area under the receiver operating characteristic curve) of combined mammography plus ultrasound vs mammography alone and the positive predictive value of biopsy recommendations for mammography plus ultrasound vs mammography alone.Forty participants (41 breasts) were diagnosed with cancer: 8 suspicious on both ultrasound and mammography, 12 on ultrasound alone, 12 on mammography alone, and 8 participants (9 breasts) on neither. The diagnostic yield for mammography was 7.6 per 1000 women

2008 JAMA PubMed

113. Single reading with computer-aided detection for screening mammography. (PubMed)

Single reading with computer-aided detection for screening mammography. The sensitivity of screening mammography for the detection of small breast cancers is higher when the mammogram is read by two readers rather than by a single reader. We conducted a trial to determine whether the performance of a single reader using a computer-aided detection system would match the performance achieved by two readers.The trial was designed as an equivalence trial, with matched-pair comparisons between (...) the cancer-detection rates achieved by single reading with computer-aided detection and those achieved by double reading. We randomly assigned 31,057 women undergoing routine screening by film mammography at three centers in England to double reading, single reading with computer-aided detection, or both double reading and single reading with computer-aided detection, at a ratio of 1:1:28. The primary outcome measures were the proportion of cancers detected according to regimen and the recall rates

2008 NEJM

114. Cost-effectiveness of digital mammography breast cancer screening. (Full text)

Cost-effectiveness of digital mammography breast cancer screening. The DMIST (Digital Mammography Imaging Screening Trial) reported improved breast cancer detection with digital mammography compared with film mammography in selected population subgroups, but it did not assess the economic value of digital relative to film mammography screening.To evaluate the cost-effectiveness of digital mammography screening for breast cancer.Validated, discrete-event simulation model.Data from DMIST (...) and publicly available U.S. data.U.S. women age 40 years or older.Lifetime.Societal and Medicare.All-film mammography screening; all-digital mammography screening; and targeted digital mammography screening, which is age-targeted digital mammography (for women <50 years of age) and age- and density-targeted digital mammography (for women <50 years of age or women > or =50 years of age with dense breasts).Cost per quality-adjusted life-year (QALY) gained.All-digital mammography screening cost $331,000 (95

2008 Annals of Internal Medicine PubMed

115. Cost-effectiveness of digital mammography breast cancer screening

Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Tosteson A N, Stout N K, Fryback D G, Acharyya S, Herman B A, Hannah L G, Pisano E D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study aimed to determine the cost-effectiveness of digital mammography screening, compared with film mammography screening, for the detection of breast cancer (BC) in women aged 40 years or more than 65 years. The study showed that screening for BC using all-digital mammography is not cost-effective, while age-targeted screening with digital mammography has the potential to be cost-effective

2008 NHS Economic Evaluation Database.

116. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost (...) with ultrasound (US) in self-referring women with dense breasts and a negative report on mammography. US detected early-stage cancers in women with mammography-negative dense breasts, especially in women younger than 50 years, but with substantial financial implications. Overall, the reporting of the clinical data was satisfactory. However, there was little information on the cost analysis and the issue of uncertainty was not addressed, so caution is required when interpreting the authors’ conclusions. Type

2008 NHS Economic Evaluation Database.

117. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

118. Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate

Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

119. Tailored interventions to promote mammography screening: A meta-analytic review. (Full text)

Tailored interventions to promote mammography screening: A meta-analytic review. OBJECTIVE: To evaluate the effectiveness of tailored interventions, designed to reach one specific person based on her unique characteristics, for promoting mammography use. METHOD: This systematic review used meta-analytic techniques to aggregate the effect size of 28 studies published from 1997 through 2005. Potential study-level moderators of outcomes (sample, intervention, and methodological characteristics (...) ) were also examined. RESULTS: A small but significant aggregate odds ratio effect size of 1.42 indicated that women exposed to tailored interventions were significantly more likely to get a mammogram (p<0.001). The type of population recruited and participants' pre-intervention level of mammography adherence did not significantly influence this effect. Tailored interventions that used the Health Belief Model and included a physician recommendation produced the strongest effects. Interventions

2007 EvidenceUpdates PubMed

120. Influence of computer-aided detection on performance of screening mammography. (Full text)

Influence of computer-aided detection on performance of screening mammography. Computer-aided detection identifies suspicious findings on mammograms to assist radiologists. Since the Food and Drug Administration approved the technology in 1998, it has been disseminated into practice, but its effect on the accuracy of interpretation is unclear.We determined the association between the use of computer-aided detection at mammography facilities and the performance of screening mammography from 1998 (...) through 2002 at 43 facilities in three states. We had complete data for 222,135 women (a total of 429,345 mammograms), including 2351 women who received a diagnosis of breast cancer within 1 year after screening. We calculated the specificity, sensitivity, and positive predictive value of screening mammography with and without computer-aided detection, as well as the rates of biopsy and breast-cancer detection and the overall accuracy, measured as the area under the receiver-operating-characteristic

2007 NEJM PubMed